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Abstract
Background: Spinal cord injury (SCI) is a widely spread pathology with currently no effective treatment for any symptom.
Regenerative medicine through cell transplantation is a very attractive strategy and may be used in different non-exclusive
ways to promote functional recovery. We investigated functional and structural outcomes after grafting human embryonic
neural progenitors (hENPs) in spinal cord-lesioned rats.
Methods and Principal Findings: With the objective of translation to clinics we have chosen a paradigm of delayed
grafting, i.e., one week after lesion, in a severe model of spinal cord compression in adult rats. hENPs were either naı ¨ve or
engineered to express Neurogenin 2 (Ngn2). Moreover, we have compared integrating and non-integrating lentiviral
vectors, since the latter present reduced risks of insertional mutagenesis. We show that transplantation of hENPs transduced
to express Ngn2 fully restore weight support and improve functional motor recovery after severe spinal cord compression at
thoracic level. This was correlated with partial restoration of serotonin innervations at lumbar level, and translocation of
5HT1A receptors to the plasma membrane of motoneurons. Since hENPs were not detectable 4 weeks after grafting,
transitory expression of Ngn2 appears sufficient to achieve motor recovery and to permit axonal regeneration. Importantly,
we also demonstrate that transplantation of naı ¨ve hENPs is detrimental to functional recovery.
Conclusions and Significance: Transplantation and short-term survival of Ngn2-expressing hENPs restore weight support
after SCI and partially restore serotonin fibers density and 5HT1A receptor pattern caudal to the lesion. Moreover, grafting of
naı ¨ve-hENPs was found to worsen the outcome versus injured only animals, thus pointing to the possible detrimental effect
of stem cell-based therapy per se in SCI. This is of major importance given the increasing number of clinical trials involving
cell grafting developed for SCI patients.
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Introduction
Spinal cord injury (SCI) is a devastating pathology with currently
no effective treatment of any symptom, that often leads to
permanent loss of motor, sensory and autonomic functions (for
review see [1,2]). In SCI, lack of spontaneous axonal regeneration,
and the correlative absence of functional recovery, is not primarily
due to an endogenous inability of axon to re-grow [3] but is
impeded by a combination of inhibitory factors, including astrocyte
scarring [4]. Many studies have investigated the effects of grafting a
variety of cells in several animal models of spinal cord injury ([5,6],
for review see [7,8,9,10,11]) and have reported beneficial but also
severe detrimental side effects [12]. Cell transplantation may be
used indifferentnon-exclusivewaystopromoteaxonalregeneration
and functional recovery after spinal traumatism: (1) to bring
permissive molecules and/or trophic factors at the lesion level to
enhance the regenerative capacity; (2) to provide a scaffold for the
regeneration of severed axons; (3) to replace lost cells. Thus, any
strategy aiming at repair of a damaged spinal cord must be
elaborated so as to fulfill one or severalof the above listed objectives.
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to differentiate into neural lineages (for review see [11]) but gene
modification prior to their transplantation may enhance their
survival,controltheirdifferentiationanddelivertransgeneproducts.
In order to reconstruct the neuronal circuitry damaged by the
lesion, transplantation of genetically modified cells expressing
proneural factors is thus an appealing therapeutic strategy.
Neurogenin-2 (Ngn2) is an attractive candidate since it is a
proneural gene involved in neuronal differentiation and subtype
specification in various regions of the nervous system but which also
inhibits astrocytic differentiation [13,14].
With the aim of translation to the clinic, we explored the
transplantation potential of hENPs either naı ¨ve, or engineered to
express Ngn2 in a severe model of spinal cord compression in
adult rats. We report here that hENPs expressing Ngn2 induce a
functional motor recovery associated with a partial restoration of
serotonin fibers and appropriate location of serotonin receptors
below the lesion site. Moreover, we evidence that hENPs
transduced with a non-integrating lentiviral vector to express
Ngn2 induce similar recovery than those transduced with an
integrating vector. Conversely, transplantation of naı ¨ve hENPs led
to worsening in functional outcome.
Results
Ngn2-hENPs improved functional motor recovery
whereas naı ¨ve hENPs worsened it
Adult rats were submitted to severe spinal cord compressive
injury at thoracic level (T8–T9) [23]. One week later (sub-acute
time window), they were transplanted with hENPs. We then
assessed their motor, sensory and reflex functions over one month,
before sacrifice. Behavioral recovery was compared in four groups
of animals: 1) injured-only animals, 2) injured animals grafted with
naı ¨ve hENPs transduced with a GFP expressing lentiviral vector,
3) animals grafted with hENPs genetically modified to express
Ngn2 with an integrating (Trip-PGK-Ngn2) vector, 4) animals
grafted with a non-integrating (Ni-Trip-PGK-Ngn2) lentiviral
vector [15].
As early as 8 and 14 days after transplantation, rats transplanted
with integrating and non-integrating Ngn2-hENP presented a
better gross motor recovery (open field, Figure 1A, inclined plan,
Figure 1C) than naı ¨ve-hENPs-grafted and injured-only animals.
Ngn2-hENPs grafted groups reached an efficient functional score
corresponding to a weight support capacity (score of 3; open field
test). One month after transplantation the percentage of animals
that were able to support their weight (score 3–6, open field) in
both Ngn2-hENPs transplanted groups was significantly higher
than in naı ¨ve-hENPs-grafted and injured-only groups (Figure 1D).
Importantly, animals grafted with naı ¨ve-hENPs had a significantly
worse gross motor recovery than injured-only rats (Figure 1A&D).
Eighteen days after transplantation, fine motor function
evaluated by a grid-navigation test was also significantly better
for Ngn2-hENPs grafted rats that presented a correct hind limb
placement (grid, score of 2) or even griping on the grid (score of 3)
(Figure 1B&E). This improvement was noticeable since 7 to 10
days post grafting. Moreover, the percentage of Ngn2-hENPs
grafted animals that reached a grid score $3 was significantly
higher when cells had been transduced with a non-integrating
vector than with an integrating vector (Figure 1E). For all
other tests, animals grafted with persistent (integrating vector) and
transient (non-integrating vector) Ngn2 expression recovered
similarly (Figure 1). No differences were observed between
all groups for sensory, reflex and autonomic functions, with
the exception of bladder control which was significantly
improved in integrating-Ngn2-hENPs grafted rats (Supplementary
Figure S1).
Lesion extension is not modified by Ngn2-hENPs
In a complementary series of experiments intended to compare
lesion extension in naı ¨ve and non-integrating-Ngn2-hENPs grafted
rats, we carried out histological analysis of the injured spinal cords
(Figure 2A–C). We evaluated the lesion area on a large segment
(3-cm corresponding to 3 metamers) of the spinal cord centered
on the lesion that included the 3 grafting points. One month
after transplantation, there was no difference in the extension
of the injury at the epicenter (non-integrating-Ngn2-hENPs:
93.1+/21.5% and naı ¨ve-hENPs: 89.9+/29.6). Means of areas
under the curves, corresponding to the total amount of damaged
tissues (that is, volumetric analysis according to the Cavalieri
principle [16]), were not significantly different in both groups
(440.5+/236.2 and 659.5+/293.6 (arbitrary units) in the non-
integrating-Ngn2-hENPs and naı ¨ve-hENPs grafted groups)
(Figure 2C). Thus, these experiments showed that Ngn2-hENPs
grafting did not reduce lesion extension and indicated that only
10% of preserved tissues at the lesion site was sufficient to permit
improvement up to full weight support.
hENPs were not present one month after grafting
One month after transplantation the fate of grafted hENPs was
analyzed on histological coronal sections through a 3 cm spinal
cord segment centered on the lesion site. Since all grafted cells
were engineered to express GFP, we first searched for green
fluorescent cells in the transplanted area. Because major auto
fluorescence was observed in all groups, including that of injured-
only rats, we further used peroxidase-conjugated secondary
antibodies to detect GFP or other specific markers. In all grafted
animal groups (naı ¨ve-hENPs, non-integrating-Ngn2-hENPs and
integrating-Ngn2-hENPs) no hENPs were ever detected using
GFP immunostaining. Since we could not exclude that GFP
expression decreased 4 weeks after transplantation and since less of
100% of the grafted cells were actually GFP positive, we searched
for the presence of the antigen HuNu to identify human cells;
again, no positive cells were ever detected. As auto fluorescence is
a known property of macrophages [17,18,19] probably due
endogenous flavoproteins [20,21] and since auto fluorescent cells
were morphologically macrophage-like cells we then searched for
the presence of macrophages. ED1 staining revealed massive
macrophage activation at the injury site and at grafting points
(Figure 2D–F) that correspond to auto fluorescent cells. At the
epicenter of the lesion macrophages were present all over the
spinal cord sections, whereas at transplantation levels macrophag-
es were localized at the injection points (Figure 2D&F) but also in
the peripheral white matter (Figure S2D&E). Macrophage
activation was similar in all-3 groups of grafted rats. In injured-
only animals, ED1 staining was similarly present at the epicenter.
Ngn2-hENP partially restored serotonin and 5HT1A
receptors expression
The raphe-spinal serotonergic system plays a major role in
locomotion and is particularly affected after SCI [22,23]. To get
further insight into the mechanism of functional improvement, we
characterized four weeks after transplantation serotonergic fibers
(5HT), on a spinal cord segment located 1 mm below the lesion
site in injured-only and grafted animals. In intact spinal cord,
serotonergic fibers were present in the ventral horn surrounding
their alpha-motoneuron targets and in the intermediolateral cell
column (IML) (Figure 3A). Five weeks after spinal cord
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injured-only and naı ¨ve-hENPs-grafted groups (Figure 3B). Con-
versely, both Ngn2-hENPs transplanted-groups (integrating and
non-integrating) presented a substantial restoration of serotonergic
profiles (Figure 3C–F). Numerous thin fibers were present over the
ventral horn in the vicinity of alpha-motoneurons (Figure 3C&E).
Serotonin expression appeared in long and varicose fibers in the
IML and spread medially toward the central canal as well as
laterally within the white matter (Figure 3D&F).
We then looked for the presence and cellular location of
corresponding receptors. In the same spinal segment 88% of
alpha-motoneurons presented a membrane-bound localization of
the serotonin receptor type 1A (5HT1A) in intact spinal cord
(Figure 3G&L) as compared to 36.4% five weeks after SCI for
injured-only rats (Figure 3H&L). Four weeks after non-integrating-
Ngn2-hENPs transplantation, sub-cellular localization of 5HT1A
expression was entirely restored to intact pattern since 92.3% of
alpha-motoneurons displayed 5HT1A expression at the mem-
brane (Figure 3I, K and L). In the naı ¨ve-hENPs group, as in
injured-only rats, only 25.8% of alpha-motoneurons expressed
5HT1A at the membrane, (Figure 3J and L).
Our results provide evidence that increased serotonergic fibers
density caudal to the lesion in Ngn2-hENPs transplanted rat is
associated with a presumed ‘‘active’’ distribution of 5HT1A
receptors. These changes coincide with improved motor function
observed in non-integrating-Ngn2-hENPs transplanted rats.
Discussion
We have shown that sub-acute transplantation of Ngn2-hENPs
in a model of severe SCI improves functional motor outcome.
Recovery is associated, below the lesion site, with partial
restoration of serotonin expression and translocation to the
membrane of 5HT1A receptors in alpha-motoneurons. Moreover,
we provide evidence that transplantation of naı ¨ve hENPs is
detrimental to functional recovery.
We have designed our experiments with the objective of
translation to the clinic. Indeed, spinal cord compression is a
major component in most human injuries and most of these
injuries are severe. Spinal balloon-compression injury in the adult
rat is a well-characterized, reproducible and predictable SCI
model; balloon inflation of 15 ml for 5 minutes in the vertebral
canal at thoracic level 9 leads to severe spinal injury associated
with complete paraplegia [24]. We have chosen a sub-acute time
window (7 days) for grafting, since earlier grafting could interfere
with spinal shock and edema whereas in the chronic phase
Figure 1. Transplantation of hENPs genetically modified to express neurogenin-2 improved functional motor recovery whereas
naı ¨ve-hENPs grafting worsened it. (A&D) Open field test: walking on the horizontal plane. (A) Open field test before and during 35 days post-
spinal compression (28 days post-transplantation (T)) for evaluation of gross motor function. From 7 days after transplantation, rats grafted with both
non-integrating and integrating-Ngn2-hENPs presented a higher motor recovery than injured-only and naı ¨ve-hENPs grafted animals. No difference was
seen between both Ngn2 groups. Rats transplanted with naı ¨ve-hENPs presented a lower recovery than injured-only animals. (D) A higher percentage of
animals transplanted with Ngn2-hENPs presented a functional motor recovery that correspond to weight support (score 3 to 6). Transplantation with
naı ¨ve-hENPs worsened motor outcomesas compared to injured-only rats. Scores: 0 corresponds to no hind limb movement andno weight bearing; 3 to
weight support and 6 to normal walking. (B&E) Grid navigation test for evaluation of fine motor coordination over a 50-cm horizontal runaway grid.
Scoresgrid:0correspondtohindlimbdragwithoutfootplacement and5tonormalwalkingoverthegridwithtoesgrippingwire.(B) From21daysafter
transplantation, rats grafted with both non-integrating and integrating-Ngn2-hENPs presented a similar higher motor recovery than injured-only and
naı ¨ve-hENPs grafted animals. (E) A higher percentage of animals transplanted with Ngn2-hENPs presented a fine motor recovery that correspond to
griping of the grid(score 3 to 5). (C) From 21 days after transplantation, rats grafted with both non-integratingandintegrating-Ngn2-hENPs presented a
similar higher performance on the inclined plan test than injured-only and naı ¨ve-hENPs grafted animals. T= transplantation. Statistical analysis: (A–C)
two-ways ANOVA analysis followed by Bonferroni’s multiple comparison test (**: p,0.01; ***: p,0.001). (D&E) Fisher’s exact test on the percentage of
animals reaching a given score one month after grafting was used (**P,0.01, ***P,0.001). Injured-only rats (control group 1, n=11); naı ¨ve-hENPs
(control group 2, n=9); Ngn2-non integrating (n=10) and Ngn2-integrating (n=6).
doi:10.1371/journal.pone.0015914.g001
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expected benefits. Transplanted cells were of human origin and, as
a tool for gene transfer, we have compared integrating and non-
integrating lentiviral vectors, since the latter associate a high
transducing efficiency with reduced risks of insertional mutagenesis
[15]. Behavioral tests [24,25,26] were chosen to evaluate authentic
functional recovery (weight support capability) rather than
modification in limbs positioning that not always represent a
functional improvement.
Others had shown that transplantation of rat adult neural stem
cells in a rodent model of spinal weight-drop injury improved
functional recovery but also increased neuropathic pain whereas
previous cells transduction with neurogenin-2 prevented astrocytic
differentiation and allodynia [12]. At variance, we did not observe
differences between all groups (injured-only, naı ¨ve-hENPs and
both hNgn2-hENPs) for sensory, reflex and autonomic functions.
In our model, severe compression of the dorsal aspect of the spinal
cord might initially produce major allodynia and/or hyperpathia
phenomena [13] that would hinder further evaluation of any
sensory worsening. Thus, our results can hardly be compared with
those of Hofstetter et al. [12] since those authors used a different
lesion model. Moreover, transplanted cells were of different origin,
since adult rat neural stem cells were grafted [12] whereas we
transplanted human embryonic neural progenitors.
Four weeks after grafting, hENPs were undetectable in the
injured spinal cord. Thus, not only does a transient expression of
Ngn2 suffice to achieve motor functional recovery but also
functional benefits obviously do not result from replacement of lost
cells. Motor recovery induced by transplanted cells appears thus to
be indirect and is likely due to activation of endogenous preserved
circuitry via trophic support supply and/or generation of favorable
substrate for axonal growth as previously hypothesized ([27], (for
reviews see [7,28]). In this respect, worth noting is the fact that no
more than 10% of spinal cord tissue was preserved at the level of
the injury. A possible alternative mechanism could be through the
protection of endogenous cells from further secondary damage,
but this appears unlikely due to the delay of one week in between
lesion and grafting.
The rapid recruitment of a large number of macrophages that
we observe at the lesion site is a well-characterized event [29,30]
and it is likely that the presence of macrophages at injection sites
results from trauma-induced inflammation due to spinal cord
needle penetration and cell transplantation. Such inflammatory
response may contribute to the loss of grafted cells that however
Figure 2. Histological analysis of the injured spinal cord. (A–C) Grafting of non-integrating-Ngn2-hENPs did not modify lesion extension after
spinal cord compression. (A&B) Photomicrographs of Luxol fast blue stained sections of an injured spinal cord grafted with naı ¨ve-hENPs. Transverse
sections of the spinal cord taken at different levels: (A) rostral to the lesion (B) Epicenter of the lesion. (C) Percentage of lesion area at the epicenter 5
weeks after spinal cord injury in non-integrating-Ngn2-hENPs and naı ¨ve-hENPs transplanted rats. At the epicenter both groups presented a lesion
area of 90% and a rostro caudal extension of 15 mm. (D–F) ED1 staining revealed massive macrophage activation at the injury site and at grafting
levels. At transplantation levels macrophages were localized at the injection point (D&F) and in the peripheral white matter (2D&E). Photographs
had been taken in a non-integrating-Ngn2-hENPs grafted rats but macrophage activation was similar in all transplanted groups. Scale bars: (A, B&D)
200 mm and (E&F)5 0mm. Naı ¨ve-hENPs (n=9); Ngn2-non integrating (n=10) and Ngn2-integrating (n=6).
doi:10.1371/journal.pone.0015914.g002
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functional recovery induced by transplantation of Ngn2-hENPs.
To conclude, transplantation of short term surviving hENPs
that express Ngn2 restores weight support and grid walk after
severe spinal cord compression. It corresponds with partial
restoration of serotonin fibers density and of an ‘‘active’’ 5HT1A
receptor pattern caudal to the lesion. Given the clear fun-
ctional improvement observed in spinal cord injured-rat trans-
planted with human neural progenitors engineered to express
Neurogenin-2, it is very important to elucidate the mechanisms of
action that underlie this positive outcomes. This will be addressed
in future studies that will be carried out at the histological and
molecular levels. Moreover, since grafting of naı ¨ve-hENPs was
found to worsen the outcome versus injured only animals, we call
attention to the possible detrimental effect of stem cell-based
therapy per se in SCI. This is of major importance given the
increasing number of clinical trials of cell grafting developed for
SCI patients.
Materials and Methods
Preparation of hENPs and viral transduction
Primary embryonic human neural progenitors (hENPs) were
obtained from dissected telencephalic vesicles of 8-weeks-old
aborted fetuses (legal date limit in the French legislation: 5–12
weeks) with the written consent of the fetus carrier, following the
French (Law nu 2004–800 published in the ‘‘Journal Officiel’’, 7
th
of August 2004), the European legislations and the Declaration of
Helsinki. The «Agence de Biome ´decine», France, gave ethic
approval for all steps of our study and for all participants.
Abortions were performed in the Hospital Robert Debre ´, Paris,
France and anonymity of the fetus carrier was preserved. Cells
were amplified in culture as previously described [31,32]. Briefly,
progenitor cells were plated at a 6610
4 cells/cm
2 density on
plastic dishes coated with 0.25% gelatin and 10 mg/ml laminin
and amplified in DMEN-F12 complemented with N2, B27 (all
from Gibco, Carlsbad, USA), bFGF (10 ng/ml) and EGF (10 ng/
Figure 3. Transplantation of hENPs genetically modified to express Ngn2 partially restored serotonergic fibbers density and
distribution of 5HT1A receptors caudal to the lesion. (A–F) Serotonin expression pattern 1 mm below the injury site 4 weeks after
transplantation. (A) Serotonergic fibbers (5HT) are located in the ventral horn of uninjured rats. (B) 5HT expression below the lesion site is
dramatically reduced in naı ¨ve-hENPs-grafted rats. (C–F) In rat transplanted with non-integrating-Ngn2-hENPs 5HT expression is partially restored
below the lesion. Thin 5HT positive fibbers are present over the ventral horn in the vicinity of motoneurons (C&E) they spread toward the central
canal (D) and the white matter (F). (G–K) Serotonin receptor type 1A (5HT1A) expression pattern 1 mm below the injury site 4 weeks after
transplantation. (G&l) In intact spinal cord almost 90% of motoneurons have a membrane-bound localization of 5HT1A. (H&L) Five weeks after
compression, 36% of motoneurons of the injured-only group have a 5HT1A membrane-bound localization as compared to 92% in the non-
integrating-Ngn2-hENPs transplanted group (I, K&L). (J&L) 25% of motoneurons in rats grafted with naı ¨ve-hENPs expressed 5HT1A at the
membrane. (L) Quantification of the motoneurons that express 5HT1A in a membrane location. One-way ANOVA analysis followed by Bonferroni’s
multiple comparison test was used for analysis of the location of 5HT1A receptors; (**: p,0.01; ***: p,0.001). Scale bars: (A, B, C&K) 200 mm and (D–
J)5 0mm. Uninjured animals (n=6), injured-only rats (n=11); Naı ¨ve-hENPs (n=9) and Ngn2-non integrating (n=10).
doi:10.1371/journal.pone.0015914.g003
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3–5 divisions using accutase (PAA, Pasching, Austria) for
dissociation. For lentiviral vector transduction, dissociated neural
stem cells were kept in the same media at a 10
6 cells/ml density
and incubated for 2 hours with 50 ng/p24 of vector stock per
1.2610
5 cells. We used four types of flap bearing HIV-1 derived
lentiviral vectors [33], either expressing GFP or human neuro-
genin-2 cDNA under control of the house keeping promoter of the
phosphoglycerate kinase promoter (PGK). Vectors either carried a
wild type or a mutant integrase (D64V mutant) leading
respectively to integrating and non-integrating phenotypes [15].
These vectors are named Trip-PGK-GFP and Trip-PGK-Ngn2
for integrating vectors and Ni-Trip-PGK-GFP and Ni-Trip-PGK-
Ngn2 for non-integrating vectors. In both cases cells transduced to
express Ngn2 were co-transduced with the respective (Trip or Ni-
Trip) PGK-GFP vectors.
Spinal cord compression and hENPs transplantation
Experimental procedures followed the European legislative,
administrative, and statutory measures for animal experimentation
(86/609/EEC). The study was approved by the ‘‘Direction des
Services Ve ´te ´rinaires de l’He ´rault’’, France (Alain Privat, autho-
rization number 34118) and ratified by the ‘‘Pre ´fecture de
l’He ´rault’’, France. Every effort was made to minimize the
number of animals and their suffering. We used 8 to 9 weeks of age
female Sprague Dawley rats (220–240 g; n=36) (Charles River,
l’Arbresles, France). Surgeries were conducted under anesthesia
with 1 L/min of O2 supply; anesthesia was induced by 4%
isoflurane and maintained at 2.5% during spinal cord compression
[24,34]. Compression injury was carried out at thoracic level 9
(T9) similarly to that described previously [24,26,35,36]. Briefly, a
burr hole was drilled in the posterior arch of T10 vertebra to insert
a 2-French Fogarty catheter (Edwards Life sciences, Horw,
Switzerland) into the epidural space; the balloon was positioned
at T9 level and water balloon inflation (15 ml) was made with a
Hamilton syringe. The inflated balloon was left in place for 5 min.
Seven days post-injury we grafted genetically engineered human
embryonic neural progenitors (hENPs) in the spinal parenchyma.
Over the course of the experiments we grafted primary hENPs
issued from two series of cell preparation emanating from the same
fetus. To ensure sufficient cell diffusion around the injury site, cells
were injected in 3 points (lesion site, below and above); burr holes
were drilled in posterior arches of T8 and T9 and T10 hole was
re-opened). We injected a total of 90,000 cells (2 ml/site;
15,000 cells/ml) using a micro-electrode (80 mm of diameter)
connected to a micro-injector (0.2 ml/min) and to a stereotactic
micromanipulator. To diminish possible deleterious effects (such as
spinal cord dissection) of transplantation that could lead to
neurological worsening, cells were injected slowly (10 min/
injection point) followed by a 5 minutes delay before needle
withdrawing to avoid loss of transplanted cells resulting from
suction phenomena. All cells were transduced to express either
GFP protein only or in combination with Ngn2. For Ngn2
transduced cells we used either integrating or non-integrating
lentiviral vectors. We thus had four animal groups: injured-only
rats (control group 1, n=11); GFP (control group 2, n=9); Ngn2-
non integrating (n=10) and Ngn2-integrating (n=6). Animals
were excluded if they encountered at least one of the following
exclusion criteria: unusual suffering, loss of weight exceeding 20%
of initial measurement and insufficient primary lesion leading to a
non-complete paraplegia before grafting. Percentages (less than
5%) of excluded animals were similar in all groups.
Animals were killed 35 days post injury with an overdose of
pentobarbital and perfused transcardially with 4% paraformalde-
hyde in PBS. For histology, a 3 cm spinal cord segment (i.e. 3
metamers) centered on the lesion was dissected, post-fixed,
cryoprotected (30% sucrose over night at 4uC) and embedded in
Tissue-Tek OCT Compound (Sakura Finetek, Torrance, CA,
USA).
Pharmacological treatment
All rats received daily sub-cutaneous injection of Cyclosporin A
(CsA) (Sandimmun, Novartis, Basel, Switzerland) 10 mg/kg. CsA
injection started 2 days prior transplantation (5 days after lesion for
injured-only rats) and until the end of the study (J35). Gentamycin
antibiotic therapy was given by daily intramuscular injection
(2 mg/kg) to avoid urinary tract infection for 15 days starting at
lesion time [37].
Behavioral monitoring
Before injury, and every third day during the whole study time,
behavioral tests were carried out for motor, sensory and reflex
functions as previously described [24,25,26]. Motor response was
evaluated by 3 tests: open field walking and inclined plan for gross
motricity and a grid-navigation test for fine motricity. Evaluation
of sensory response consisted on pain and heat withdrawal for
superficial function and proprioception for deep function. Reflexes
were evaluated by hind limb withdrawal after manual extension
and toes extension when the animal is picked up by the tail.
Bladder function was assessed every day and manually emptied
until subjects regained control. An independent experienced
individual carried out all evaluations on a blind basis.
Histology and immunohistochemistry
Lesion extension was analyzed on 12 mm-thick cryosections of a
3 cm spinal cord segment centered on the lesion site; one section
each 360 mm was stained with luxol fast blue. Morphometric
quantification of injured tissues was done on scanned images
(Nano Zoomer Digital Pathology System, Hamamatsu, Japan)
with MetaMorph software (MDS Analytical Technologies,
Canada) as previously described [24,26].
For immunohistochemistry, 12 mm sections of the same spinal
segment were mounted on slides, washed in PBS (5 min), treated
for 30 min in PBS containing lysine (20 mM, pH 7.4) and for
20 min in 3% H2O2). Tissue sections were then permeabilized and
blocked for 30 min with PBS containing bovine serum albumin
(BSA, 10%) and Triton X-100 (0.1%).
Rat polyclonal anti-ED1 (1:500; Serotec, Oxford, UK), rabbit
anti-5-hydroxytryptamine (1:30000; Immunotech, Marseille,
France), rabbit anti-5HT1A (1:500; a gift from Dr. Michel
Hamon INSERM U677 Neuropsychopharmacology Unit, Paris,
France), mouse anti-GFP (1:500; Abcam, Cambridge, UK) and
mouse anti-HuNu (1:250; Chemicon, Bilerica, USA) primary
antibodies were used. Secondary peroxydase-conjugated antibod-
ies (Immunotech, Marseille, France) were used at a 1:500 dilution.
The sections were scanned and analyzed (Nano Zoomer Digital
Pathology System, Hamamatsu, Japan). The controls were done
in the absence of the primary antibody and were negative in all
cases.
Statistical analyses
Behavioral analysis: two-ways ANOVA analysis followed by
Bonferroni’s multiple comparison test or Fisher’s exact test on the
percentage of animals rising a given score. T test was used for
lesion extension at the epicenter and areas under the curves. One-
way ANOVA analysis was used for analysis of the location of
5HT1A receptors; (*: P,0.05; **: p,0.01; ***: p,0.001).
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Figure S1 Transplantation of hENPs did not modify
sensory outcomes but bladder control was improved in
by integrating-Ngn2-hENPs grafting. (A) Pain and (B) heat
withdrawal was used to evaluate superficial sensory function.
Scores range from normal response (0) to hyperalgesia (4). No
difference was seen between groups, they were all similarly
hyperalgesic. (C) Deep sensory function was evaluated by means of
placement response of the hind limb (proprioception). (D) Reflexes
were evaluated by hind limb withdrawal after manual extension;
both groups presented similar deficits. Scores range from normal
response (0) to hyper reaction (3). (E) Autonomic function
corresponds to bladder control. Scores: no bladder control (0)
and bladder control (1). (A–E) Statistical analysis: two-ways
ANOVA analysis followed by Bonferroni’s multiple comparison
test. T: transplantation. Injured-only rats (control group 1, n=11);
naı ¨ve-hENPs (control group 2, n=9); Ngn2-non integrating
(n=10) and Ngn2-integrating (n=6).
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